Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 750,100 shares, a growth of 41.9% from the September 15th total of 528,600 shares. Based on an average daily trading volume, of 1,965,600 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily trading volume, of 1,965,600 shares, the days-to-cover ratio is presently 0.4 days.
Cresco Labs Stock Performance
CRLBF opened at $1.22 on Friday. The company has a market capitalization of $434.23 million, a price-to-earnings ratio of -9.38 and a beta of 1.52. The company has a debt-to-equity ratio of 1.33, a current ratio of 3.10 and a quick ratio of 2.22. Cresco Labs has a 1-year low of $0.43 and a 1-year high of $1.65. The business has a 50 day moving average price of $1.24 and a two-hundred day moving average price of $0.85.
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last released its earnings results on Thursday, August 7th. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01). The firm had revenue of $163.62 million during the quarter, compared to analyst estimates of $162.00 million. Cresco Labs had a negative return on equity of 11.77% and a negative net margin of 6.67%. Research analysts predict that Cresco Labs will post -0.2 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on Cresco Labs
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
See Also
- Five stocks we like better than Cresco Labs
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- Transportation Stocks Investing
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- How to trade penny stocks: A step-by-step guide
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.
